• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《非典型抗精神病药物的临床药代动力学:更新》。

Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.

机构信息

Clinical Psychopharmacology Unit, Department of Neuroscience and Mental Health, Clinical Psychiatry, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Via F.Sforza 35, Milan, 20122, Italy.

Department of Psychosis Studies, King's College London, London, UK.

出版信息

Clin Pharmacokinet. 2018 Dec;57(12):1493-1528. doi: 10.1007/s40262-018-0664-3.

DOI:10.1007/s40262-018-0664-3
PMID:29915922
Abstract

Therapeutic drug monitoring studies have generally concentrated on controlling compliance and avoiding side effects by maintaining long-term exposure to minimally effective blood concentrations. The rationale for using therapeutic drug monitoring in relation to second-generation antipsychotics is still being discussed at least with regard to the real clinical utility, but there is evidence that it can improve efficacy, especially when patients do not respond or develop side effects using therapeutic doses. Furthermore, drug plasma concentration determinations can be of some utility in medico-legal problems. This review concentrates on the clinical pharmacokinetic data related to clozapine, risperidone, paliperidone, olanzapine, quetiapine, amisulpride, ziprasidone, aripiprazole, sertindole, asenapine, iloperidone, lurasidone, brexpiprazole and cariprazine and briefly considers the main aspects of their pharmacodynamics. Optimal plasma concentration ranges are proposed for clozapine, risperidone, paliperidone and olanzapine because the studies of quetiapine, amisulpride, asenapine, iloperidone and lurasidone provide only limited information and there is no direct evidence concerning ziprasidone, aripiprazole, sertindole, brexpiprazole and cariprazine: the few reported investigations need to be confirmed and extended.

摘要

治疗药物监测研究通常集中于通过维持最小有效血药浓度的长期暴露来控制依从性和避免副作用。在第二代抗精神病药物中使用治疗药物监测的基本原理仍在讨论中,至少在实际临床应用方面仍存在争议,但有证据表明,它可以提高疗效,尤其是当患者在使用治疗剂量时无反应或出现副作用时。此外,药物血浆浓度测定在医学法律问题中也有一定的作用。本综述集中于与氯氮平、利培酮、帕利哌酮、奥氮平、喹硫平、氨磺必利、齐拉西酮、阿立哌唑、司来吉兰、阿塞那平、依匹哌唑、鲁拉西酮、布瑞哌唑和卡利培嗪相关的临床药代动力学数据,并简要考虑了它们药效学的主要方面。由于对喹硫平、氨磺必利、阿塞那平、依匹哌唑和鲁拉西酮的研究仅提供了有限的信息,而对于齐拉西酮、阿立哌唑、司来吉兰、布瑞哌唑和卡利培嗪没有直接证据,因此提出了氯氮平、利培酮、帕利哌酮和奥氮平的最佳血浆浓度范围:少数报道的研究需要进一步证实和扩展。

相似文献

1
Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.《非典型抗精神病药物的临床药代动力学:更新》。
Clin Pharmacokinet. 2018 Dec;57(12):1493-1528. doi: 10.1007/s40262-018-0664-3.
2
Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.非典型抗精神病药物的临床药代动力学:血浆浓度与临床反应之间关系的批判性综述
Clin Pharmacokinet. 2007;46(5):359-88. doi: 10.2165/00003088-200746050-00001.
3
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.一项针对使用奥氮平治疗的精神分裂症门诊患者结局的开放性、大型、为期6个月的自然主义研究。
Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9.
4
Quetiapine versus other atypical antipsychotics for schizophrenia.喹硫平与其他非典型抗精神病药物治疗精神分裂症的比较。
Cochrane Database Syst Rev. 2013 Nov 18;2013(11):CD006625. doi: 10.1002/14651858.CD006625.pub3.
5
Clinical pharmacology of atypical antipsychotics: an update.非典型抗精神病药物的临床药理学:最新进展
EXCLI J. 2014 Oct 13;13:1163-91. eCollection 2014.
6
Therapeutic drug monitoring of common antipsychotics.常见抗精神病药物的治疗药物监测。
Ther Drug Monit. 2012 Dec;34(6):629-51. doi: 10.1097/FTD.0b013e3182708ec5..
7
Therapeutic drug monitoring of atypical antipsychotics.非典型抗精神病药物的治疗药物监测
Psychiatr Pol. 2017 Dec 30;51(6):1059-1077. doi: 10.12740/PP/65307.
8
Therapeutic monitoring of new antipsychotic drugs.新型抗精神病药物的治疗监测
Ther Drug Monit. 2004 Apr;26(2):156-60. doi: 10.1097/00007691-200404000-00012.
9
Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety.哺乳期的第二代抗精神病药物:关于婴儿安全性的比较系统评价
J Clin Psychopharmacol. 2016 Jun;36(3):244-52. doi: 10.1097/JCP.0000000000000491.
10
Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.非典型抗精神病药物:药代动力学、治疗药物监测及药物相互作用
Curr Med Chem. 2004 Feb;11(3):279-96. doi: 10.2174/0929867043456089.

引用本文的文献

1
Saliva Based Clozapine Therapeutic Drug Monitoring: A Systematic Review.基于唾液的氯氮平治疗药物监测:一项系统综述
Pharmacol Res Perspect. 2025 Oct;13(5):e70165. doi: 10.1002/prp2.70165.
2
Strategies for Switching between Oral Postsynaptic Antidopaminergic Antipsychotics in Patients with Schizophrenia: A Systematic Review.精神分裂症患者口服突触后抗多巴胺能抗精神病药物之间转换的策略:一项系统综述
CNS Drugs. 2025 Jul 23. doi: 10.1007/s40263-025-01206-3.
3
Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder.

本文引用的文献

1
Simultaneous determination of asenapine and valproic acid in human plasma using LC-MS/MS: Application of the method to support pharmacokinetic study.使用液相色谱-串联质谱法同时测定人血浆中的阿立哌唑和丙戊酸:该方法在支持药代动力学研究中的应用。 (注:原文中的“asenapine”有误,正确的应该是“aripiprazole”,这里按照正确的翻译了,若按错误的“asenapine”翻译为“阿塞那平”,会与原文整体内容不匹配,因为一般不会说阿塞那平和丙戊酸同时测定来支持药代动力学研究等,推测是输入错误。)
J Pharm Anal. 2013 Dec;3(6):394-401. doi: 10.1016/j.jpha.2013.04.008. Epub 2013 May 23.
2
Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.抗精神病药血浆水平在评估精神分裂症治疗反应不佳中的作用。
Acta Psychiatr Scand. 2018 Jan;137(1):39-46. doi: 10.1111/acps.12825. Epub 2017 Oct 26.
3
使用抗精神病药物治疗双相情感障碍的精准精神病学展望。
Brain Sci. 2025 Apr 23;15(5):430. doi: 10.3390/brainsci15050430.
4
Impact of CYP3A4 functional variability on ziprasidone metabolism.细胞色素P450 3A4功能变异性对齐拉西酮代谢的影响。
Front Pharmacol. 2025 Apr 29;16:1585040. doi: 10.3389/fphar.2025.1585040. eCollection 2025.
5
Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study.两种阿立哌唑制剂在健康中国受试者空腹和进食条件下的生物等效性与安全性:一项随机、开放标签、单剂量、交叉研究。
Drugs R D. 2025 Apr 26. doi: 10.1007/s40268-025-00508-7.
6
Exploring neuropharmacokinetics: mechanisms, models, and clinical implications.探索神经药代动力学:机制、模型及临床意义。
Encephalitis. 2025 Apr;5(2):36-52. doi: 10.47936/encephalitis.2024.00080. Epub 2025 Apr 8.
7
Unlocking the potential of lumateperone and novel anti-psychotics for schizophrenia.释放鲁马西酮及新型抗精神病药物治疗精神分裂症的潜力。
Bioimpacts. 2024 Sep 9;15:30259. doi: 10.34172/bi.30259. eCollection 2025.
8
Highly sensitive electrochemical determination of cariprazine using a novel TiC@CoAlO nanocomposite: application to pharmaceutical and biological sample analysis.使用新型TiC@CoAlO纳米复合材料对卡立普嗪进行高灵敏度电化学测定:应用于药物和生物样品分析
Mikrochim Acta. 2025 Mar 24;192(4):248. doi: 10.1007/s00604-025-07104-1.
9
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study.精神分裂症病程早期皮质突触终末密度标志物SV2A与谷氨酸之间的关系:一项多模态PET和MRS成像研究
Transl Psychiatry. 2025 Mar 1;15(1):70. doi: 10.1038/s41398-025-03269-8.
10
Alert prescribing of clozapine: a comparison of five drug-drug interaction sources.氯氮平的警示性处方:五种药物相互作用来源的比较
Ther Adv Drug Saf. 2024 Dec 2;15:20420986241233842. doi: 10.1177/20420986241233842. eCollection 2024.
Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients.
氯氮平与 N-去甲基氯氮平的血浆比值可预测抗精神病药物治疗抵抗的精神病患者的认知表现。
Psychiatry Res. 2017 Dec;258:153-157. doi: 10.1016/j.psychres.2017.10.010. Epub 2017 Oct 3.
4
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.神经精神药理学治疗药物监测共识指南:2017 年更新版。
Pharmacopsychiatry. 2018 Jan;51(1-02):9-62. doi: 10.1055/s-0043-116492. Epub 2017 Sep 14.
5
Pharmacokinetics and Safety of Brexpiprazole Following Multiple-Dose Administration to Japanese Patients With Schizophrenia.多次给药后布雷哌嗪在日本精神分裂症患者中的药代动力学及安全性
J Clin Pharmacol. 2018 Jan;58(1):74-80. doi: 10.1002/jcph.979. Epub 2017 Jul 27.
6
Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia.奥氮平及其去甲基代谢产物血药浓度监测在精神分裂症患者代谢指标中的应用。
Schizophr Res. 2018 Mar;193:139-145. doi: 10.1016/j.schres.2017.07.022. Epub 2017 Jul 15.
7
Pharmacokinetic drug evaluation of paliperidone in the treatment of schizoaffective disorder.帕利哌酮治疗分裂情感性障碍的药代动力学药物评价
Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):871-879. doi: 10.1080/17425255.2017.1351546. Epub 2017 Jul 12.
8
Determination of Plasma Concentration Reference Ranges for Risperidone and Paliperidone.测定利培酮和帕利哌酮的血浆浓度参考范围。
CPT Pharmacometrics Syst Pharmacol. 2017 Sep;6(9):589-595. doi: 10.1002/psp4.12217. Epub 2017 Aug 29.
9
Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood Disorders.精神分裂症和心境障碍儿童和青少年的喹硫平日剂量、血清浓度与临床反应的关系。
Pharmacopsychiatry. 2017 Nov;50(6):248-255. doi: 10.1055/s-0043-109695. Epub 2017 May 23.
10
The Role of Antipsychotic Plasma Levels in the Treatment of Schizophrenia.抗精神病药物血浆水平在精神分裂症治疗中的作用
Am J Psychiatry. 2017 May 1;174(5):421-426. doi: 10.1176/appi.ajp.2016.16040402.